line_item,period,value,symbol
Tax Effect Of Unusual Items,2023-03-31 00:00:00,1450868.325783,EMMIL.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.21857,EMMIL.NS
Normalized EBITDA,2023-03-31 00:00:00,139155000.0,EMMIL.NS
Total Unusual Items,2023-03-31 00:00:00,6638000.0,EMMIL.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,6638000.0,EMMIL.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,79001000.0,EMMIL.NS
Reconciled Depreciation,2023-03-31 00:00:00,19522000.0,EMMIL.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,674950000.0,EMMIL.NS
EBITDA,2023-03-31 00:00:00,145793000.0,EMMIL.NS
EBIT,2023-03-31 00:00:00,126271000.0,EMMIL.NS
Net Interest Income,2023-03-31 00:00:00,-25914000.0,EMMIL.NS
Interest Expense,2023-03-31 00:00:00,25173000.0,EMMIL.NS
Interest Income,2023-03-31 00:00:00,508000.0,EMMIL.NS
Normalized Income,2023-03-31 00:00:00,73813868.325783,EMMIL.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,79001000.0,EMMIL.NS
Total Expenses,2023-03-31 00:00:00,870213000.0,EMMIL.NS
Diluted Average Shares,2023-03-31 00:00:00,,EMMIL.NS
Basic Average Shares,2023-03-31 00:00:00,,EMMIL.NS
Diluted EPS,2023-03-31 00:00:00,,EMMIL.NS
Basic EPS,2023-03-31 00:00:00,,EMMIL.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,79001000.0,EMMIL.NS
Net Income Common Stockholders,2023-03-31 00:00:00,79001000.0,EMMIL.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,EMMIL.NS
Net Income,2023-03-31 00:00:00,79001000.0,EMMIL.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,79001000.0,EMMIL.NS
Net Income Extraordinary,2023-03-31 00:00:00,0.0,EMMIL.NS
Net Income Discontinuous Operations,2023-03-31 00:00:00,0.0,EMMIL.NS
Net Income Continuous Operations,2023-03-31 00:00:00,79001000.0,EMMIL.NS
Tax Provision,2023-03-31 00:00:00,22097000.0,EMMIL.NS
Pretax Income,2023-03-31 00:00:00,101098000.0,EMMIL.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,2084000.0,EMMIL.NS
Special Income Charges,2023-03-31 00:00:00,6638000.0,EMMIL.NS
Other Special Charges,2023-03-31 00:00:00,-4095000.0,EMMIL.NS
Write Off,2023-03-31 00:00:00,-2543000.0,EMMIL.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-25914000.0,EMMIL.NS
Total Other Finance Cost,2023-03-31 00:00:00,1249000.0,EMMIL.NS
Interest Expense Non Operating,2023-03-31 00:00:00,25173000.0,EMMIL.NS
Interest Income Non Operating,2023-03-31 00:00:00,508000.0,EMMIL.NS
Operating Income,2023-03-31 00:00:00,119934000.0,EMMIL.NS
Operating Expense,2023-03-31 00:00:00,195263000.0,EMMIL.NS
Other Operating Expenses,2023-03-31 00:00:00,69796000.0,EMMIL.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,19522000.0,EMMIL.NS
Amortization,2023-03-31 00:00:00,383000.0,EMMIL.NS
Depreciation Income Statement,2023-03-31 00:00:00,19139000.0,EMMIL.NS
Selling General And Administration,2023-03-31 00:00:00,16023000.0,EMMIL.NS
Selling And Marketing Expense,2023-03-31 00:00:00,3060000.0,EMMIL.NS
General And Administrative Expense,2023-03-31 00:00:00,12963000.0,EMMIL.NS
Gross Profit,2023-03-31 00:00:00,315197000.0,EMMIL.NS
Cost Of Revenue,2023-03-31 00:00:00,674950000.0,EMMIL.NS
Total Revenue,2023-03-31 00:00:00,990147000.0,EMMIL.NS
Operating Revenue,2023-03-31 00:00:00,990147000.0,EMMIL.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,1214246.69545,EMMIL.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.255685,EMMIL.NS
Normalized EBITDA,2022-03-31 00:00:00,80853000.0,EMMIL.NS
Total Unusual Items,2022-03-31 00:00:00,4749000.0,EMMIL.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,4749000.0,EMMIL.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,33617000.0,EMMIL.NS
Reconciled Depreciation,2022-03-31 00:00:00,17773000.0,EMMIL.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,573656000.0,EMMIL.NS
EBITDA,2022-03-31 00:00:00,85602000.0,EMMIL.NS
EBIT,2022-03-31 00:00:00,67829000.0,EMMIL.NS
Net Interest Income,2022-03-31 00:00:00,-23132000.0,EMMIL.NS
Interest Expense,2022-03-31 00:00:00,22664000.0,EMMIL.NS
Interest Income,2022-03-31 00:00:00,653000.0,EMMIL.NS
Normalized Income,2022-03-31 00:00:00,30082246.69545,EMMIL.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,33617000.0,EMMIL.NS
Total Expenses,2022-03-31 00:00:00,720692000.0,EMMIL.NS
Diluted Average Shares,2022-03-31 00:00:00,11326500.0,EMMIL.NS
Basic Average Shares,2022-03-31 00:00:00,11326500.0,EMMIL.NS
Diluted EPS,2022-03-31 00:00:00,2.967995,EMMIL.NS
Basic EPS,2022-03-31 00:00:00,2.967995,EMMIL.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,33617000.0,EMMIL.NS
Net Income Common Stockholders,2022-03-31 00:00:00,33617000.0,EMMIL.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,EMMIL.NS
Net Income,2022-03-31 00:00:00,33617000.0,EMMIL.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,33617000.0,EMMIL.NS
Net Income Extraordinary,2022-03-31 00:00:00,0.0,EMMIL.NS
Net Income Discontinuous Operations,2022-03-31 00:00:00,0.0,EMMIL.NS
Net Income Continuous Operations,2022-03-31 00:00:00,33617000.0,EMMIL.NS
Tax Provision,2022-03-31 00:00:00,11548000.0,EMMIL.NS
Pretax Income,2022-03-31 00:00:00,45165000.0,EMMIL.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,3655000.0,EMMIL.NS
Special Income Charges,2022-03-31 00:00:00,4749000.0,EMMIL.NS
Other Special Charges,2022-03-31 00:00:00,-2201000.0,EMMIL.NS
Write Off,2022-03-31 00:00:00,-2548000.0,EMMIL.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-23132000.0,EMMIL.NS
Total Other Finance Cost,2022-03-31 00:00:00,1121000.0,EMMIL.NS
Interest Expense Non Operating,2022-03-31 00:00:00,22664000.0,EMMIL.NS
Interest Income Non Operating,2022-03-31 00:00:00,653000.0,EMMIL.NS
Operating Income,2022-03-31 00:00:00,59620000.0,EMMIL.NS
Operating Expense,2022-03-31 00:00:00,147036000.0,EMMIL.NS
Other Operating Expenses,2022-03-31 00:00:00,52319000.0,EMMIL.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,17773000.0,EMMIL.NS
Amortization,2022-03-31 00:00:00,336000.0,EMMIL.NS
Depreciation Income Statement,2022-03-31 00:00:00,17437000.0,EMMIL.NS
Selling General And Administration,2022-03-31 00:00:00,9144000.0,EMMIL.NS
Selling And Marketing Expense,2022-03-31 00:00:00,959000.0,EMMIL.NS
General And Administrative Expense,2022-03-31 00:00:00,8185000.0,EMMIL.NS
Gross Profit,2022-03-31 00:00:00,206656000.0,EMMIL.NS
Cost Of Revenue,2022-03-31 00:00:00,573656000.0,EMMIL.NS
Total Revenue,2022-03-31 00:00:00,780312000.0,EMMIL.NS
Operating Revenue,2022-03-31 00:00:00,780312000.0,EMMIL.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,37794.282226,EMMIL.NS
Tax Rate For Calcs,2021-03-31 00:00:00,0.030115,EMMIL.NS
Normalized EBITDA,2021-03-31 00:00:00,49868000.0,EMMIL.NS
Total Unusual Items,2021-03-31 00:00:00,1255000.0,EMMIL.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,1255000.0,EMMIL.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,9533000.0,EMMIL.NS
Reconciled Depreciation,2021-03-31 00:00:00,18176000.0,EMMIL.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,345240000.0,EMMIL.NS
EBITDA,2021-03-31 00:00:00,51123000.0,EMMIL.NS
EBIT,2021-03-31 00:00:00,32947000.0,EMMIL.NS
Net Interest Income,2021-03-31 00:00:00,-24549000.0,EMMIL.NS
Interest Expense,2021-03-31 00:00:00,23118000.0,EMMIL.NS
Interest Income,2021-03-31 00:00:00,596000.0,EMMIL.NS
Normalized Income,2021-03-31 00:00:00,8315794.282226,EMMIL.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,9533000.0,EMMIL.NS
Total Expenses,2021-03-31 00:00:00,448677000.0,EMMIL.NS
Diluted Average Shares,2021-03-31 00:00:00,11326500.0,EMMIL.NS
Basic Average Shares,2021-03-31 00:00:00,11326500.0,EMMIL.NS
Diluted EPS,2021-03-31 00:00:00,0.841655,EMMIL.NS
Basic EPS,2021-03-31 00:00:00,0.841655,EMMIL.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,9533000.0,EMMIL.NS
Net Income Common Stockholders,2021-03-31 00:00:00,9533000.0,EMMIL.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,0.0,EMMIL.NS
Net Income,2021-03-31 00:00:00,9533000.0,EMMIL.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,9533000.0,EMMIL.NS
Net Income Extraordinary,2021-03-31 00:00:00,0.0,EMMIL.NS
Net Income Discontinuous Operations,2021-03-31 00:00:00,0.0,EMMIL.NS
Net Income Continuous Operations,2021-03-31 00:00:00,9533000.0,EMMIL.NS
Tax Provision,2021-03-31 00:00:00,296000.0,EMMIL.NS
Pretax Income,2021-03-31 00:00:00,9829000.0,EMMIL.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,6684000.0,EMMIL.NS
Special Income Charges,2021-03-31 00:00:00,1255000.0,EMMIL.NS
Other Special Charges,2021-03-31 00:00:00,-1289000.0,EMMIL.NS
Write Off,2021-03-31 00:00:00,34000.0,EMMIL.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,-24549000.0,EMMIL.NS
Total Other Finance Cost,2021-03-31 00:00:00,2027000.0,EMMIL.NS
Interest Expense Non Operating,2021-03-31 00:00:00,23118000.0,EMMIL.NS
Interest Income Non Operating,2021-03-31 00:00:00,596000.0,EMMIL.NS
Operating Income,2021-03-31 00:00:00,25573000.0,EMMIL.NS
Operating Expense,2021-03-31 00:00:00,103437000.0,EMMIL.NS
Other Operating Expenses,2021-03-31 00:00:00,28786000.0,EMMIL.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,18176000.0,EMMIL.NS
Amortization,2021-03-31 00:00:00,1232000.0,EMMIL.NS
Depreciation Income Statement,2021-03-31 00:00:00,16944000.0,EMMIL.NS
Selling General And Administration,2021-03-31 00:00:00,5251000.0,EMMIL.NS
Selling And Marketing Expense,2021-03-31 00:00:00,841000.0,EMMIL.NS
General And Administrative Expense,2021-03-31 00:00:00,4410000.0,EMMIL.NS
Gross Profit,2021-03-31 00:00:00,129010000.0,EMMIL.NS
Cost Of Revenue,2021-03-31 00:00:00,345240000.0,EMMIL.NS
Total Revenue,2021-03-31 00:00:00,474250000.0,EMMIL.NS
Operating Revenue,2021-03-31 00:00:00,474250000.0,EMMIL.NS
